Business
Paradigm doses first participant in Synovial Fluid Trial
Paradigm doses first participant in Synovial Fluid Trial
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":263,"tagName":"div"}]